tiprankstipranks
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market
1244
3D Medicines, Inc.
RESEARCH TOOLSreports
Want to see HK:1244 full AI Analyst Report?

3D Medicines, Inc. (1244) Financial Statements

3 Followers

3D Medicines, Inc. Financial Overview

3D Medicines, Inc.'s market cap is currently HK$613.17M. The company's EPS TTM is HK$-0.72; its P/E ratio is -2.73; 3D Medicines, Inc. is scheduled to report earnings on August 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 356.09M¥ 445.65M¥ 634.95M¥ 567.39M¥ 60.26M
Gross Profit¥ 298.97M¥ 371.74M¥ 524.01M¥ 525.18M¥ 55.98M
Operating Income¥ -112.65M¥ -123.43M¥ -497.25M¥ -386.17M¥ -516.25M
EBITDA¥ -197.43M¥ -226.95M¥ -529.23M¥ -1.03B¥ -1.45B
Net Income¥ -177.53M¥ -182.66M¥ -524.70M¥ -1.02B¥ -1.43B
Balance Sheet
Cash & Short-Term Investments¥ 438.10M¥ 840.98M¥ 996.58M¥ 942.03M¥ 824.48M
Total Assets¥ 936.64M¥ 1.22B¥ 1.43B¥ 1.33B¥ 1.06B
Total Debt¥ 152.85M¥ 237.62M¥ 282.43M¥ 175.70M¥ 3.15B
Net Debt¥ -17.46M¥ -206.70M¥ -384.05M¥ -521.04M¥ 2.38B
Total Liabilities¥ 391.54M¥ 512.54M¥ 558.20M¥ 436.65M¥ 3.33B
Stockholders' Equity¥ 596.98M¥ 785.06M¥ 936.74M¥ 943.00M¥ -2.24B
Cash Flow
Free Cash Flow¥ -149.87M¥ -249.60M¥ -150.74M¥ -332.76M¥ -433.46M
Operating Cash Flow¥ -149.85M¥ -210.58M¥ -144.41M¥ -278.78M¥ -377.08M
Investing Cash Flow¥ -26.20M¥ 17.95M¥ -187.58M¥ -242.11M¥ -98.87M
Financing Cash Flow¥ -89.56M¥ -33.92M¥ 304.51M¥ 408.41M¥ 840.08M
Currency in CNY

3D Medicines, Inc. Earnings and Revenue History

Income Statement >

3D Medicines, Inc. Debt to Assets

Balance Sheet >

3D Medicines, Inc. Cash Flow

Cash Flow >

3D Medicines, Inc. Forecast EPS vs Actual EPS

Earnings >